Early Parkinson Disease
2 clinical trials · Condition
◉ Watch Early Parkinson Disease
| Record | Firm | Date |
|---|---|---|
| PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 (NCT03655236) | Sun Pharma Advanced Research Company Limited | 2019-02-18 |
| Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease (NCT00809302) | Neurogen Corporation | 2008-12-01 |
Track Early Parkinson Disease automatically
Every clearance here is in the API, with alerts when new ones post.